The DOI matches its Crossref record; 108 of the 108 references it cites were found in a registry or an index.
Induction of Immunity to Human Immunodeficiency Virus Type-1 by Vaccination
Open accessAbstract
SUMMARY Recent findings have brought optimism that development of a successful human immunodeficiency virus type-1 (HIV-1) vaccine lies within reach. Studies of early events in HIV-1 infection have revealed when and where HIV-1 is potentially vulnerable to vaccine-targeted immune responses. With technical advances in human monoclonal antibody production, clues about how antibodies recognize the HIV-1 envelope proteins have uncovered new antigenic targets for immunogen design. A recent vaccine regimen has shown modest efficacy against HIV-1 acquisition. However, inducing long-term T and B cell memory and coping with HIV-1 diversity remain a high priority. Mediators of innate immunity may play pivotal roles in blocking infection and shaping immunity; vaccine strategies to capture these activities are under intense investigation. Key challenges remain in integrating basic, preclinical and clinical research to improve predictions of types of immunity associated with vaccine efficacy, to apply these insights to immunogen design, and to accelerate evaluation of vaccine efficacy in persons at-risk for acquiring infection.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
Rerks-Ngarm, S., Pitisuttithum, P., Nitayaphan, S., Kaewkungwal, J., Chiu, J., Paris, R., Premsri, N., Namwat, C., de Souza, M., Adams, E., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0908492 · Cited by 3,034
PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression
Day, C. L., Kaufmann, D. E., Kiepiela, P., Brown, J. A., Moodley, E. S., Reddy, S., Mackey, E. W., Miller, J. D., Leslie, A. J., DePierres, C., et al. (2006) · Nature · doi:10.1038/nature05115 · Cited by 2,680
Abdool Karim, Q., Abdool Karim, S. S., Frohlich, J. A., Grobler, A. C., Baxter, C., Mansoor, L. E., Kharsany, A. B. M., Sibeko, S., Mlisana, K. P., Omar, Z., et al. (2010) · Science · doi:10.1126/science.1193748 · Cited by 2,435
Antibody neutralization and escape by HIV-1
Wei, X., Decker, J. M., Wang, S., Hui, H., Kappes, J. C., Wu, X., Salazar-Gonzalez, J. F., Salazar, M. G., Kilby, J. M., Saag, M. S., et al. (2003) · Nature · doi:10.1038/nature01470 · Cited by 2,421
Predominant Autoantibody Production by Early Human B Cell Precursors
Wardemann, H., Yurasov, S., Schaefer, A., Young, J. W., Meffre, E., & Nussenzweig, M. C. (2003) · Science · doi:10.1126/science.1086907 · Cited by 2,083
Keele, B. F., Giorgi, E. E., Salazar-Gonzalez, J. F., Decker, J. M., Pham, K. T., Salazar, M. G., Sun, C., Grayson, T., Wang, S., Li, H., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802203105 · Cited by 1,912
Self-citationRational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Wu, X., Yang, Z.-Y., Li, Y., Hogerkorp, C.-M., Schief, W. R., Seaman, M. S., Zhou, T., Schmidt, S. D., Wu, L., Xu, L., et al. (2010) · Science · doi:10.1126/science.1187659 · Cited by 1,730
Broad and Potent Neutralizing Antibodies from an African Donor Reveal a New HIV-1 Vaccine Target
Walker, L. M., Phogat, S. K., Chan-Hui, P.-Y., Wagner, D., Phung, P., Goss, J. L., Wrin, T., Simek, M. D., Fling, S., Mitcham, J. L., et al. (2009) · Science · doi:10.1126/science.1178746 · Cited by 1,723
Buchbinder, S. P., Mehrotra, D. V., Duerr, A., Fitzgerald, D. W., Mogg, R., Li, D., Gilbert, P. B., Lama, J. R., Marmor, M., del Rio, C., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61591-3 · Cited by 1,713
Self-citationUpregulation of PD-1 expression on HIV-specific CD8+ T cells leads to reversible immune dysfunction
Trautmann, L., Janbazian, L., Chomont, N., Said, E. A., Gimmig, S., Bessette, B., Boulassel, M.-R., Delwart, E., Sepulveda, H., Balderas, R. S., et al. (2006) · Nature Medicine · doi:10.1038/nm1482 · Cited by 1,565
A Whole-Genome Association Study of Major Determinants for Host Control of HIV-1
Fellay, J., Shianna, K. V., Ge, D., Colombo, S., Ledergerber, B., Weale, M., Zhang, K., Gumbs, C., Castagna, A., Cossarizza, A., et al. (2007) · Science · doi:10.1126/science.1143767 · Cited by 1,235
Self-citationRapid evolution of the neutralizing antibody response to HIV type 1 infection
Richman, D. D., Wrin, T., Little, S. J., & Petropoulos, C. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0630530100 · Cited by 1,200
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01
Zhou, T., Georgiev, I., Wu, X., Yang, Z.-Y., Dai, K., Finzi, A., Do Kwon, Y., Scheid, J. F., Shi, W., Xu, L., et al. (2010) · Science · doi:10.1126/science.1192819 · Cited by 1,130
CD8+ T-cell responses to different HIV proteins have discordant associations with viral load
Kiepiela, P., Ngumbela, K., Thobakgale, C., Ramduth, D., Honeyborne, I., Moodley, E., Reddy, S., de Pierres, C., Mncube, Z., Mkhwanazi, N., et al. (2007) · Nature Medicine · doi:10.1038/nm1520 · Cited by 1,032
The rgp120 HIV Vaccine Study Group (2005) · The Journal of Infectious Diseases · doi:10.1086/428404 · Cited by 952
Fc receptor but not complement binding is important in antibody protection against HIV
Hessell, A. J., Hangartner, L., Hunter, M., Havenith, C. E. G., Beurskens, F. J., Bakker, J. M., Lanigan, C. M. S., Landucci, G., Forthal, D. N., Parren, P. W. H. I., et al. (2007) · Nature · doi:10.1038/nature06106 · Cited by 901
Kwong, P. D., Doyle, M. L., Casper, D. J., Cicala, C., Leavitt, S. A., Majeed, S., Steenbeke, T. D., Venturi, M., Chaiken, I., Fung, M., et al. (2002) · Nature · doi:10.1038/nature01188 · Cited by 889
The immune response during acute HIV-1 infection: clues for vaccine development
McMichael, A. J., Borrow, P., Tomaras, G. D., Goonetilleke, N., & Haynes, B. F. (2010) · Nature Reviews Immunology · doi:10.1038/nri2674 · Cited by 871
Self-citationBroad diversity of neutralizing antibodies isolated from memory B cells in HIV-infected individuals
Scheid, J. F., Mouquet, H., Feldhahn, N., Seaman, M. S., Velinzon, K., Pietzsch, J., Ott, R. G., Anthony, R. M., Zebroski, H., Hurley, A., et al. (2009) · Nature · doi:10.1038/nature07930 · Cited by 867
Pitisuttithum, P., Gilbert, P., Gurwith, M., Heyward, W., Martin, M., van Griensven, F., Hu, D., Tappero, J. W., Choopanya, K., & Bangkok Vaccine Evaluation Group (2006) · The Journal of Infectious Diseases · doi:10.1086/508748 · Cited by 847
Antibody Domain Exchange Is an Immunological Solution to Carbohydrate Cluster Recognition
Calarese, D. A., Scanlan, C. N., Zwick, M. B., Deechongkit, S., Mimura, Y., Kunert, R., Zhu, P., Wormald, M. R., Stanfield, R. L., Roux, K. H., et al. (2003) · Science · doi:10.1126/science.1083182 · Cited by 781
Cardiolipin Polyspecific Autoreactivity in Two Broadly Neutralizing HIV-1 Antibodies
Haynes, B. F., Fleming, J., St. Clair, E. W., Katinger, H., Stiegler, G., Kunert, R., Robinson, J., Scearce, R. M., Plonk, K., Staats, H. F., et al. (2005) · Science · doi:10.1126/science.1111781 · Cited by 744
Self-citationAlmeida, J. R., Price, D. A., Papagno, L., Arkoub, Z. A., Sauce, D., Bornstein, E., Asher, T. E., Samri, A., Schnuriger, A., Theodorou, I., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070784 · Cited by 714
HIV-1 vaccine-induced immunity in the test-of-concept Step Study: a case–cohort analysis
McElrath, M. J., De Rosa, S. C., Moodie, Z., Dubey, S., Kierstead, L., Janes, H., Defawe, O. D., Carter, D. K., Hural, J., Akondy, R., et al. (2008) · The Lancet · doi:10.1016/s0140-6736(08)61592-5 · Cited by 713
Self-citationHansen, S. G., Vieville, C., Whizin, N., Coyne-Johnson, L., Siess, D. C., Drummond, D. D., Legasse, A. W., Axthelm, M. K., Oswald, K., Trubey, C. M., et al. (2009) · Nature Medicine · doi:10.1038/nm.1935 · Cited by 675
Scanlan, C. N., Pantophlet, R., Wormald, M. R., Saphire, E. O., Stanfield, R., Wilson, I. A., Katinger, H., Dwek, R. A., Rudd, P. M., & Burton, D. R. (2002) · Journal of Virology · doi:10.1128/jvi.76.14.7306-7321.2002 · Cited by 665
Longhi, M. P., Trumpfheller, C., Idoyaga, J., Caskey, M., Matos, I., Kluger, C., Salazar, A. M., Colonna, M., & Steinman, R. M. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090247 · Cited by 663
Goonetilleke, N., Liu, M. K. P., Salazar-Gonzalez, J. F., Ferrari, G., Giorgi, E., Ganusov, V. V., Keele, B. F., Learn, G. H., Turnbull, E. L., Salazar, M. G., et al. (2009) · Journal of Experimental Medicine · doi:10.1084/jem.20090365 · Cited by 641
Self-citationSáez-Cirión, A., Lacabaratz, C., Lambotte, O., Versmisse, P., Urrutia, A., Boufassa, F., Barré-Sinoussi, F., Delfraissy, J.-F., Sinet, M., Pancino, G., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0611244104 · Cited by 616
Simek, M. D., Rida, W., Priddy, F. H., Pung, P., Carrow, E., Laufer, D. S., Lehrman, J. K., Boaz, M., Tarragona-Fiol, T., Miiro, G., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00110-09 · Cited by 594
Targeting early infection to prevent HIV-1 mucosal transmission
Haase, A. T. (2010) · Nature · doi:10.1038/nature08757 · Cited by 593
Migueles, S. A., Osborne, C. M., Royce, C., Compton, A. A., Joshi, R. P., Weeks, K. A., Rood, J. E., Berkley, A. M., Sacha, J. B., Cogliano-Shutta, N. A., et al. (2008) · Immunity · doi:10.1016/j.immuni.2008.10.010 · Cited by 590
Hessell, A. J., Poignard, P., Hunter, M., Hangartner, L., Tehrani, D. M., Bleeker, W. K., Parren, P. W. H. I., Marx, P. A., & Burton, D. R. (2009) · Nature Medicine · doi:10.1038/nm.1974 · Cited by 546
Hessell, A. J., Rakasz, E. G., Poignard, P., Hangartner, L., Landucci, G., Forthal, D. N., Koff, W. C., Watkins, D. I., & Burton, D. R. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000433 · Cited by 497
Ofek, G., Tang, M., Sambor, A., Katinger, H., Mascola, J. R., Wyatt, R., & Kwong, P. D. (2004) · Journal of Virology · doi:10.1128/jvi.78.19.10724-10737.2004 · Cited by 490
Impact of MHC class I diversity on immune control of immunodeficiency virus replication
Goulder, P. J. R., & Watkins, D. I. (2008) · Nature Reviews Immunology · doi:10.1038/nri2357 · Cited by 460
Alter, G., Martin, M. P., Teigen, N., Carr, W. H., Suscovich, T. J., Schneidewind, A., Streeck, H., Waring, M., Meier, A., Brander, C., et al. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20070695 · Cited by 455
Cardoso, R. M. F., Zwick, M. B., Stanfield, R. L., Kunert, R., Binley, J. M., Katinger, H., Burton, D. R., & Wilson, I. A. (2005) · Immunity · doi:10.1016/j.immuni.2004.12.011 · Cited by 449
Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants
Fischer, W., Perkins, S., Theiler, J., Bhattacharya, T., Yusim, K., Funkhouser, R., Kuiken, C., Haynes, B., Letvin, N. L., Walker, B. D., et al. (2007) · Nature Medicine · doi:10.1038/nm1461 · Cited by 446
Self-citationNeutralizing antibodies generated during natural HIV-1 infection: good news for an HIV-1 vaccine?
Stamatatos, L., Morris, L., Burton, D. R., & Mascola, J. R. (2009) · Nature Medicine · doi:10.1038/nm.1949 · Cited by 430
Polyreactivity increases the apparent affinity of anti-HIV antibodies by heteroligation
Mouquet, H., Scheid, J. F., Zoller, M. J., Krogsgaard, M., Ott, R. G., Shukair, S., Artyomov, M. N., Pietzsch, J., Connors, M., Pereyra, F., et al. (2010) · Nature · doi:10.1038/nature09385 · Cited by 427
The Role of Antibodies in HIV Vaccines
Mascola, J. R., & Montefiori, D. C. (2010) · Annual Review of Immunology · doi:10.1146/annurev-immunol-030409-101256 · Cited by 388
Mosaic HIV-1 vaccines expand the breadth and depth of cellular immune responses in rhesus monkeys
Barouch, D. H., O'Brien, K. L., Simmons, N. L., King, S. L., Abbink, P., Maxfield, L. F., Sun, Y.-H., La Porte, A., Riggs, A. M., Lynch, D. M., et al. (2010) · Nature Medicine · doi:10.1038/nm.2089 · Cited by 384
Walker, L. M., Simek, M. D., Priddy, F., Gach, J. S., Wagner, D., Zwick, M. B., Phogat, S. K., Poignard, P., & Burton, D. R. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1001028 · Cited by 370
Labrijn, A. F., Poignard, P., Raja, A., Zwick, M. B., Delgado, K., Franti, M., Binley, J., Vivona, V., Grundner, C., Huang, C.-C., et al. (2003) · Journal of Virology · doi:10.1128/jvi.77.19.10557-10565.2003 · Cited by 357
Gilbert, P. B., Peterson, M. L., Follmann, D., Hudgens, M. G., Francis, D. P., Gurwith, M., Heyward, W. L., Jobes, D. V., Popovic, V., Self, S. G., et al. (2005) · The Journal of Infectious Diseases · doi:10.1086/428405 · Cited by 355
Lambotte, O., Ferrari, G., Moog, C., Yates, N. L., Liao, H.-X., Parks, R. J., Hicks, C. B., Owzar, K., Tomaras, G. D., Montefiori, D. C., et al. (2009) · AIDS · doi:10.1097/qad.0b013e328329f97d · Cited by 342
Self-citationEnvelope glycans of immunodeficiency virions are almost entirely oligomannose antigens
Doores, K. J., Bonomelli, C., Harvey, D. J., Vasiljevic, S., Dwek, R. A., Burton, D. R., Crispin, M., & Scanlan, C. N. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1006498107 · Cited by 329
O'Brien, S. J., & Nelson, G. W. (2004) · Nature Genetics · doi:10.1038/ng1369 · Cited by 319
Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology
Pulendran, B. (2009) · Nature Reviews Immunology · doi:10.1038/nri2629 · Cited by 305
Harari, A., Bart, P.-A., Stöhr, W., Tapia, G., Garcia, M., Medjitna-Rais, E., Burnet, S., Cellerai, C., Erlwein, O., Barber, T., et al. (2008) · The Journal of Experimental Medicine · doi:10.1084/jem.20071331 · Cited by 300
Design and Pre-Clinical Evaluation of a Universal HIV-1 Vaccine
Létourneau, S., Im, E.-J., Mashishi, T., Brereton, C., Bridgeman, A., Yang, H., Dorrell, L., Dong, T., Korber, B., McMichael, A. J., et al. (2007) · PLoS ONE · doi:10.1371/journal.pone.0000984 · Cited by 281
The site and stage of anti-DNA B-cell deletion
Chen, C., Nagy, Z., Radic, M. Z., Hardy, R. R., Huszar, D., Camper, S. A., & Weigert, M. (1995) · Nature · doi:10.1038/373252a0 · Cited by 274
Few and Far Between: How HIV May Be Evading Antibody Avidity
Klein, J. S., & Bjorkman, P. J. (2010) · PLoS Pathogens · doi:10.1371/journal.ppat.1000908 · Cited by 271
Xiao, X., Chen, W., Feng, Y., Zhu, Z., Prabakaran, P., Wang, Y., Zhang, M.-Y., Longo, N. S., & Dimitrov, D. S. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.09.029 · Cited by 260
Liao, H.-X., Levesque, M. C., Nagel, A., Dixon, A., Zhang, R., Walter, E., Parks, R., Whitesides, J., Marshall, D. J., Hwang, K.-K., et al. (2009) · Journal of Virological Methods · doi:10.1016/j.jviromet.2009.02.014 · Cited by 255
Self-citationRole of HIV membrane in neutralization by two broadly neutralizing antibodies
Alam, S. M., Morelli, M., Dennison, S. M., Liao, H.-X., Zhang, R., Xia, S.-M., Rits-Volloch, S., Sun, L., Harrison, S. C., Haynes, B. F., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0908713106 · Cited by 250
Self-citationSantra, S., Liao, H.-X., Zhang, R., Muldoon, M., Watson, S., Fischer, W., Theiler, J., Szinger, J., Balachandran, H., Buzby, A., et al. (2010) · Nature Medicine · doi:10.1038/nm.2108 · Cited by 235
Self-citationPancera, M., McLellan, J. S., Wu, X., Zhu, J., Changela, A., Schmidt, S. D., Yang, Y., Zhou, T., Phogat, S., Mascola, J. R., et al. (2010) · Journal of Virology · doi:10.1128/jvi.00966-10 · Cited by 224
A fusion-intermediate state of HIV-1 gp41 targeted by broadly neutralizing antibodies
Frey, G., Peng, H., Rits-Volloch, S., Morelli, M., Cheng, Y., & Chen, B. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0800255105 · Cited by 222
Sodora, D. L., Allan, J. S., Apetrei, C., Brenchley, J. M., Douek, D. C., Else, J. G., Estes, J. D., Hahn, B. H., Hirsch, V. M., Kaur, A., et al. (2009) · Nature Medicine · doi:10.1038/nm.2013 · Cited by 220
Variable Fitness Impact of HIV-1 Escape Mutations to Cytotoxic T Lymphocyte (CTL) Response
Troyer, R. M., McNevin, J., Liu, Y., Zhang, S. C., Krizan, R. W., Abraha, A., Tebit, D. M., Zhao, H., Avila, S., Lobritz, M. A., et al. (2009) · PLoS Pathogens · doi:10.1371/journal.ppat.1000365 · Cited by 196
Self-citationVasan, S., Hurley, A., Schlesinger, S. J., Hannaman, D., Gardiner, D. F., Dugin, D. P., Boente-Carrera, M., Vittorino, R., Caskey, M., Andersen, J., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019252 · Cited by 190
Verkoczy, L., Diaz, M., Holl, T. M., Ouyang, Y.-B., Bouton-Verville, H., Alam, S. M., Liao, H.-X., Kelsoe, G., & Haynes, B. F. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0912914107 · Cited by 190
Self-citationHIV-1 Group M Conserved Elements Vaccine
Rolland, M., Nickle, D. C., & Mullins, J. I. (2007) · PLoS Pathogens · doi:10.1371/journal.ppat.0030157 · Cited by 190
HIV infection of the genital mucosa in women
Hladik, F., & Hope, T. J. (2009) · Current HIV/AIDS Reports · doi:10.1007/s11904-009-0004-1 · Cited by 184
Gray, G., Buchbinder, S., & Duerr, A. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833d2d2b · Cited by 172
Tudor, D., Derrien, M., Diomede, L., Drillet, A.-S., Houimel, M., Moog, C., Reynes, J., Lopalco, L., & Bomsel, M. (2009) · Mucosal Immunology · doi:10.1038/mi.2009.89 · Cited by 170
Gnann, J. W., Schwimmbeck, P. L., Nelson, J. A., Truax, A. B., & Oldstone, M. B. A. (1987) · Journal of Infectious Diseases · doi:10.1093/infdis/156.2.261 · Cited by 165
Benlahrech, A., Harris, J. D., Meiser, A., Papagatsias, T., Hornig, J., Hayes, P., Lieber, A., Athanasopoulos, T., Bachy, V. S., Csomor, E., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0907898106 · Cited by 164
Structure–function relationships of HIV-1 envelope sequence-variable regions refocus vaccine design
Zolla‐Pazner, S., & Cardozo, T. J. (2010) · Nature reviews. Immunology · doi:10.1038/nri2801 · Cited by 163
Xiao, P., Zhao, J., Patterson, L. J., Brocca‐Cofano, E., Venzon, D. J., Kozlowski, P. A., Hidajat, R., Demberg, T., & Robert-Guroff, M. (2010) · Journal of Virology · doi:10.1128/jvi.00410-10 · Cited by 154
FcγRIIa Genotype Predicts Progression of HIV Infection
Forthal, D. N., Landucci, G., Bream, J. H., Jacobson, L. P., Phan, T. B., & Montoya, B. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.11.7916 · Cited by 153
Meffre, E., Milili, M., Blanco-Betancourt, C., Antunes, H., Nussenzweig, M. C., & Schiff, C. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13051 · Cited by 152
Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine
Catanzaro, A. T., Roederer, M., Koup, R. A., Bailer, R. T., Enama, M. E., Nason, M., Martin, J. E., Rucker, S., Andrews, C. A., Gomez, P. L., et al. (2007) · Vaccine · doi:10.1016/j.vaccine.2007.02.050 · Cited by 151
Binley, J. Μ., Ban, Y. A., Crooks, E. T., Eggink, D., Osawa, K., Schief, W. R., & Sanders, R. W. (2010) · Journal of Virology · doi:10.1128/jvi.00105-10 · Cited by 148
Therapeutic antibodies, vaccines and antibodyomes
Dimitrov, D. S. (2010) · mAbs · doi:10.4161/mabs.2.3.11779 · Cited by 143
Novel adenovirus vector-based vaccines for HIV-1
Barouch, D. H. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833cfe4c · Cited by 135
Florese, R. H., Demberg, T., Xiao, P., Kuller, L., Larsen, K., Summers, L. E., Venzon, D. J., Cafaro, A., Ensoli, B., & Robert-Guroff, M. (2009) · The Journal of Immunology · doi:10.4049/jimmunol.0803115 · Cited by 132
Gilbert, P. B., Wang, M., Wrin, T., Petropoulos, C., Gurwith, M., Sinangil, F., D’Souza, P., Rodriguez-Chavez, I. R., deCamp, A. C., Giganti, M., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/654816 · Cited by 132
Immune memory redefined: characterizing the longevity of natural killer cells
Sun, J. C.-Y., Beilke, J. N., & Lanier, L. L. (2010) · Immunological Reviews · doi:10.1111/j.1600-065x.2010.00900.x · Cited by 129
Evolution of CD8+ T Cell Immunity and Viral Escape Following Acute HIV-1 Infection
Cao, J., McNevin, J. P., Malhotra, U., & McElrath, M. J. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.7.3837 · Cited by 127
Self-citationHorton, H., Frank, I., Baydo, R. O., Jalbert, E., Penn, J., Wilson, S., McNevin, J. P., McSweyn, M. D., Lee, D., Huang, Y., et al. (2006) · The Journal of Immunology · doi:10.4049/jimmunol.177.10.7406 · Cited by 126
Self-citationWilson, N. A., Keele, B. F., Reed, J. S., Piaskowski, S. M., MacNair, C. E., Bett, A. J., Liang, X., Wang, F., Thoryk, E. A., Heidecker, G. J., et al. (2009) · Journal of Virology · doi:10.1128/jvi.00272-09 · Cited by 124
Malhotra, U., Holte, S., Dutta, S., et al. (2001) · Journal of Clinical Investigation · doi:10.1172/jci11275 · Cited by 122
Palker, T. J., Matthews, T. J., Clark, M. E., Cianciolo, G. J., Randall, R. R., Langlois, A. J., White, G. C., Safai, B., D, R. S. M., & Bolognesi, D. P. (1987) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.84.8.2479 · Cited by 120
Challenges for structure-based HIV vaccine design
Schief, W. R., Ban, Y. A., & Stamatatos, L. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832e6184 · Cited by 120
Control of HIV-1 infection by soluble factors of the immune response
DeVico, A. L., & Gallo, R. C. (2004) · Nature Reviews Microbiology · doi:10.1038/nrmicro878 · Cited by 115
Increased levels of galactose-deficient IgG in sera of HIV-1-infected individuals
Moore, J. S., Wu, X., Kulhavy, R., Tomana, M., Novak, J., Moldoveanu, Z., Brown, R., Goepfert, P. A., & Mestecky, J. (2005) · AIDS · doi:10.1097/01.aids.0000161767.21405.68 · Cited by 108
Astronomo, R. D., Lee, H., Scanlan, C. N., Pantophlet, R. A., Huang, C., Wilson, I. A., Blixt, O., Dwek, R. A., Wong, C., & Burton, D. R. (2008) · Journal of Virology · doi:10.1128/jvi.00293-08 · Cited by 108
Kibuuka, H. N., Kimutai, R., Maboko, L., Sawe, F. K., Schunk, M., Kroidl, A., Shaffer, D., Eller, L. A., Kibaya, R. M., Eller, M. A., et al. (2010) · The Journal of Infectious Diseases · doi:10.1086/650299 · Cited by 106
Diskin, R., Marcovecchio, P., & Björkman, P. J. (2010) · Nature Structural & Molecular Biology · doi:10.1038/nsmb.1796 · Cited by 91
Selection of potent immunological adjuvants for vaccine construction
McElrath, M. J. (1995) · Seminars in Cancer Biology · doi:10.1016/1044-579x(95)90007-1 · Cited by 89
Self-citationPoxvirus vector-based HIV vaccines
Pantaleo, G., Estéban, M., Jacobs, B. L., & Tartaglia, J. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833d1e87 · Cited by 87
Okoye, A. A., Park, H., Rohankhedkar, M., Coyne-Johnson, L., Lum, R., Walker, J. M., Planer, S. L., Legasse, A. W., Sylwester, A. W., Piatak, M., et al. (2009) · The Journal of Experimental Medicine · doi:10.1084/jem.20090356 · Cited by 86
Specificity of the autologous neutralizing antibody response
Moore, P. L., Gray, E. S., & Morris, L. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832ea7e8 · Cited by 70
Pietzsch, J., Scheid, J. F., Mouquet, H., Klein, F., Seaman, M. S., Janković, M., Corti, D., Lanzavecchia, A., & Nussenzweig, M. C. (2010) · The Journal of Experimental Medicine · doi:10.1084/jem.20101176 · Cited by 67
Role of adjuvants in modeling the immune response
Carter, D., & Reed, S. G. (2010) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32833d2cdb · Cited by 64
Progress towards development of an HIV vaccine: report of the AIDS Vaccine 2009 Conference
Ross, A. L., Bråve, A., Scarlatti, G., Manrique, A., & Buonaguro, L. (2010) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(10)70069-4 · Cited by 62
Neutralizing antibodies against HIV-1: can we elicit them with vaccines and how much do we need?
Montefiori, D. C., & Mascola, J. R. (2009) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0b013e32832f4a4d · Cited by 61
Zheng, N. N., Kiviat, N. B., Sow, P. S., Hawes, S. E., Wilson, A. J., Agne, H. D., Critchlow, C. W., Gottlieb, G. S., Musey, L. K., & McElrath, M. J. (2004) · Journal of Virology · doi:10.1128/jvi.78.24.13934-13942.2004 · Cited by 55
Self-citationLessons from Failure—Preparing for Future HIV‐1 Vaccine Efficacy Trials
Graham, B. S., & Mascola, J. R. (2005) · The Journal of Infectious Diseases · doi:10.1086/428406 · Cited by 53
Asmuth, D. M., Brown, E. L., DiNubile, M. J., Sun, X., del Río, C., Harro, C. D., Keefer, M. C., Kublin, J. G., Dubey, S. A., Kierstead, L. S., et al. (2009) · The Journal of Infectious Diseases · doi:10.1086/648591 · Cited by 53
Virus-Specific CD8+T-Cell Responses Better Define HIV Disease Progression than HLA Genotype
Dinges, W. L., Richardt, J., Friedrich, D. A., Jalbert, E., Liu, Y., Stevens, C. E., Maenza, J. R., Collier, A. C., Geraghty, D. E., Smith, J., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02438-09 · Cited by 52
Self-citationRecognition sites on human IgG for Fcγ receptors: the role of glycosylation
Jefferis, R., Lund, J., & Goodall, M. D. (1995) · Immunology Letters · doi:10.1016/0165-2478(94)00201-2 · Cited by 44
Fellay, J., Frahm, N., Shianna, K. V., Cirulli, E. T., Casimiro, D. R., Robertson, M. N., Haynes, B. F., Geraghty, D. E., McElrath, M. J., & Goldstein, D. B. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiq125 · Cited by 42
Self-citationVasan, S., Hurley, A., Schlesinger, S., et al. (2009) · Retrovirology · doi:10.1186/1742-4690-6-s3-o31 · Cited by 8
OA06-06 LB. Evidence of vaccine-induced changes in breakthrough HIV-1 strains from the Step trial
Rolland, M., Tovanabutra, S., Gilbert, P. B., Sanders‐Buell, E., Heath, L., deCamp, A. C., Magaret, C. A., Bose, M., Bradfield, A., O’Sullivan, A. M., et al. (2009) · Retrovirology · doi:10.1186/1742-4690-6-s3-o42 · Cited by 5
Self-citation
Cited by
Cohen, M. S., Shaw, G. M., McMichael, A. J., & Haynes, B. F. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1011874 · Cited by 660
Self-citationA vaccine strategy that protects against genital herpes by establishing local memory T cells
Shin, H., & Iwasaki, A. (2012) · Nature · doi:10.1038/nature11522 · Cited by 646
From Vaccines to Memory and Back
Sallusto, F., Lanzavecchia, A., Araki, K., & Ahmed, R. (2010) · Immunity · doi:10.1016/j.immuni.2010.10.008 · Cited by 637
B-cell–lineage immunogen design in vaccine development with HIV-1 as a case study
Haynes, B. F., Kelsoe, G., Harrison, S. C., & Kepler, T. B. (2012) · Nature Biotechnology · doi:10.1038/nbt.2197 · Cited by 486
Self-citationYates, N. L., Liao, H.-X., Fong, Y., deCamp, A., Vandergrift, N. A., Williams, W. T., Alam, S. M., Ferrari, G., Yang, Z.-Y., Seaton, K. E., et al. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3007730 · Cited by 450
Self-citation
Metadata
- Authors
- McElrath, M. J., & Haynes, B. F.
- Venue
- Immunity
- Publisher
- Elsevier BV
- Published
- 2010-10
- Volume
- 33
- Issue
- 4
- Pages
- 542-554
- ISSN
- 1074-7613 (ISSN-L)
- OpenAlex
- W2040878504
- Cited by
- 270
- References
- 108
- FWCI
- 15.78
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.